kyle fox · Director of Policy, Finance Canada (FIN)
3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.Read more
1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).
Kyle Fox · Deputy Director of Policy, Finance Canada (FIN)
2) Support Imperial Tobacco Canada's public policy engagement strategy related to Zonnic, a nicotine pouch approved by Health Canada.Read more
3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.
1) Regulations related to nicotine replacement therapies approved by Health Canada under the Food and Drugs Act (FDA).
3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.Read more
3) discuss Zonnic as part of a broader harm reduction framework and to promote the role of regulated nicotine replacement therapies (NRTs) in helping adult smokers quit combustible tobacco.Read more
From the Office of the Commissioner of Lobbying's open data, published November 5, 2026.
Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month.
Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means.
Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence.
PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.